The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Restless Leg Syndrome Market In 2026 And What Value Is Projected For 2030?
The restless leg syndrome market has seen rapid growth in recent years. This market is anticipated to expand from $2.16 billion in 2025 to $2.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.4%. The historical growth can be linked to factors like the increasing diagnosis of neurological disorders, the rising prevalence of iron deficiency conditions, growing awareness regarding sleep-related health issues, the expansion of neurology specialty clinics, and improved access to oral medications.
The restless leg syndrome market is anticipated to experience substantial growth in the upcoming years, projected to reach $4.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This expansion during the forecast period is driven by several factors, including an intensified focus on personalized neurological therapies, an increasing demand for long-term symptom management solutions, the broadening of digital sleep health tools, expanded research into non-dopaminergic treatments, and a rise in patient awareness and diagnosis rates. Significant trends expected in the forecast period involve a greater uptake of dopamine modulating therapies, an increased adoption of non-pharmacological treatment approaches, a growing emphasis on sleep disorder management, the extension of personalized treatment strategies, and improved awareness of secondary RLS causes.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21274&type=smp
What Key Drivers Are Influencing The Growth Of The Restless Leg Syndrome Market?
The restless leg syndrome market is anticipated to expand due to the growing occurrence of iron deficiency. This condition, where the body lacks sufficient iron for healthy red blood cell production, manifests through symptoms like fatigue, weakness, and pale skin. Its rising prevalence can be attributed to factors such as inadequate dietary intake, blood loss, malabsorption disorders, and increased iron needs during pregnancy or growth. Treatments for restless leg syndrome frequently involve iron supplementation or dietary adjustments, which not only alleviate uncomfortable urges and sensations but also correct the underlying iron deficiency by replenishing the body’s iron stores, enhancing red blood cell production, and restoring proper neurological function. As an illustration, the Nation Health Service England, an England-based government agency, recorded 191,927 admissions related to iron deficiency in the 2023-24 period, marking an 11% increase from 2022-23, as reported in January 2025. Hence, the increasing prevalence of iron deficiency significantly contributes to the growth of the restless leg syndrome market.
What Are The Key Segments Of The Restless Leg Syndrome Market?
The restless leg syndrome market covered in this report is segmented –
1) By Type: Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome
2) By Treatment Type: Medicine And Devices, Surgery
3) By Route Of Administration: Oral, Injectable
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Neurological Treatment, Sleep Disorders, Movement Disorders, Symptom Management
Subsegments:
1) By Primary Restless Legs Syndrome: Idiopathic Restless Legs Syndrome, Hereditary Restless Legs Syndrome
2) By Secondary Restless Legs Syndrome: Iron Deficiency-related Restless Legs Syndrome, Chronic Kidney Disease-related Restless Legs Syndrome, Pregnancy-related Restless Legs Syndrome, Medication-induced Restless Legs Syndrome
Which Trends Are Influencing The Restless Leg Syndrome Market?
Leading companies in the restless leg syndrome (RLS) market are dedicated to creating groundbreaking solutions, like novel non-invasive therapies, to enhance symptom management and improve outcomes for patients. Novel non-invasive therapies are defined as innovative medical treatments that do not involve surgery or piercing the skin, aiming to relieve various conditions through advanced techniques such as electrical stimulation, light therapy, or external devices. For example, in April 2023, Varco Leg Care, an India-based consumer health-technology company, obtained FDA De Novo approval for its NTX100 Tonic Motor Activation (TOMAC) System. The NTX100 Tonic Motor Activation (TOMAC) System is intended to treat moderate to severe restless legs syndrome (RLS) symptoms and boost sleep quality in patients who do not respond to medications. The device functions by electrically stimulating the peroneal nerves on both sides of the body to create tonic, sustained muscle activation, which is compatible with sleep. This activation aids in suppressing the symptoms of restless leg syndrome (RLS).
Who Are The Leading Companies Operating In The Restless Leg Syndrome Market?
Major companies operating in the restless leg syndrome market are Pfizer Inc., Roche Holding AG, Merck And Co Inc., Novartis International AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., UCB S.A., Kyowa Kirin Co Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Mundipharma International Limited, Azurity Pharmaceuticals LLC, Otsuka Pharmaceutical Co Ltd., Horizon Therapeutics plc, Mylan N.V., Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Cipla Ltd., Dr Reddys Laboratories Ltd., Hikma Pharmaceuticals plc, Almirall S.A.
Read the full restless leg syndrome market report here:
https://www.thebusinessresearchcompany.com/report/restless-leg-syndrome-global-market-report
Which Region Is Expected To Register The Fastest Growth In The Restless Leg Syndrome Market?
Europe was the largest region in the restless leg syndrome market in 2025. North-America is expected to be the fastest-growing region in the forecast period. The regions covered in the restless leg syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Restless Leg Syndrome Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=21274&type=smp
Browse Through More Reports Similar to the Global Restless Leg Syndrome Market 2026, By The Business Research Company
Antiviral Combination Therapy Global Market Report
https://www.thebusinessresearchcompany.com/report/antiviral-combination-therapy-global-market-report
Respiratory Disease Vaccine Global Market Report
https://www.thebusinessresearchcompany.com/report/respiratory-disease-vaccine-global-market-report
Oncolytic Virus Therapy Global Market Report
https://www.thebusinessresearchcompany.com/report/oncolytic-virus-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model